Full Press Release Details
SS Innovations Surpasses Milestone of 100 Installations
of the SSi Mantra Surgical Robotic System
Continuing strong procedure growth, including
an upsurge in telesurgeries
Fort Lauderdale, FL - July 15, 2025
- SS Innovations International, Inc. (the "Company" or "SS Innovations") (Nasdaq: SSII), a developer
of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today
announced that the Company has installed more than 100 SSi Mantra surgical robotic systems in India and six other countries. To date,
more than 5,000 surgical procedures have been successfully performed utilizing the SSi Mantra, including 240 cardiac surgeries and 32
telesurgeries. As of December 31, 2024, a total of 2,759 robotic surgeries had been successfully completed using the SSi Mantra, including
151 cardiac surgeries and 9 telesurgeries.
Dr. Sudhir Srivastava, Chairman of the Board and
Chief Executive Officer of SS Innovations, commented, "We are thrilled to surpass the milestone of 100 installations of our SSi
Mantra surgical robotic system in India and beyond. We are seeing growing demand for and acceptance of the SSi Mantra, which reflects
its premium quality, innovative features, ease of use, improved patient experience, and overall cost-effectiveness. We aim to democratize
access to cutting edge robotic surgery through deploying SSi Mantra in existing markets while simultaneously pursuing new geographies.
In that regard, we expect to submit a De Novo application for approval to market the SSi Mantra to the U.S. Food and Drug Administration
by the end of July 2025 for multiple indications and continue along the pathway towards a European Union CE marking certification as soon
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII)
develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a
larger segment of the global population. The Company's product range includes its proprietary "SSi Mantra" surgical
robotic system and its comprehensive suite of "SSi Mudra" surgical instruments, which support a variety of surgical procedures
including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its
technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company's website at ssinnovations.com
or LinkedIn for more information and updates.
About the SSi Mantra
The SSi Mantra surgical robotic system is a user-friendly,
modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon
command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of
the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the
table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over
40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has
been clinically validated in India in more than 100 different types of surgical procedures.
Forward Looking Statements
This press release may contain statements that
are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.
The words "anticipate," "assume," "believe," "estimate," "expect," "will,"
"intend," "may," "plan," "project," "should," "could," "seek,"
"designed," "potential," "forecast," "target," "objective," "goal,"
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or SS Innovations' future financial performance and involve known and unknown risks, uncertainties and other factors that
may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels
of activity, performance or achievements expressed or implied by these forward-looking statements.
Devin Sullivan, Managing Director